Blueprint Medicines Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) ...Middle East

PR Newswire - News
Blueprint Medicines Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CAMBRIDGE, Mass., Jan. 4, 2023 /PRNewswire/ -- Blueprint Medicines Corporation (Nasdaq: BPMC), a precision therapy company focused on genomically defined cancers, rare diseases and cancer immunotherapy, today announced that, effective January 1, 2023, the Compensation Committee of...

Read More Details
Finally We wish PressBee provided you with enough information of ( Blueprint Medicines Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) )

Apple Storegoogle play

Also on site :